Oseltamivir Prophylaxis Dosing for Children
Dose and Weight‑Based Algorithm
- For a child weighing approximately 18 kg (≈40 lb), the recommended prophylactic dose of oseltamivir is 45 mg once daily. This aligns with the American Academy of Pediatrics (AAP) recommendation for the 15–23 kg weight category. [1][2]3
- The AAP weight‑based dosing schedule for post‑exposure prophylaxis is:
- ≤15 kg (≤33 lb): 30 mg once daily
- >15–23 kg (33–51 lb): 45 mg once daily
- >23–40 kg (51–88 lb): 60 mg once daily
- >40 kg (>88 lb): 75 mg once daily
Duration and Timing of Prophylaxis
- The AAP (2024‑2025) advises a 7‑day course after the last known exposure for routine post‑exposure prophylaxis; earlier guidelines recommended 10 days. [2][3][1][4]5
- Prophylaxis should be initiated within 48 hours of exposure to achieve efficacy. [2][3]
- In institutional outbreaks, extend prophylaxis to a minimum of 14 days and continue for 7 days after the last identified case. [2][3]
Formulation and Administration
- Oral suspension (6 mg/mL): 45 mg dose = 7.5 mL once daily. [1][2]3
- Capsules: One 45‑mg capsule taken once daily is an alternative. [1][2]3
- Oseltamivir may be taken with or without food; co‑administration with meals may improve gastrointestinal tolerability. [1][2]3
Clinical Considerations
- Oseltamivir prophylaxis does not replace annual influenza vaccination; it should be used only as an adjunct measure. [2][3]
- Age restrictions: The FDA has not approved prophylactic use in children < 1 year old, and the AAP does not recommend prophylaxis for infants < 3 months due to limited safety/efficacy data. [2][3]
- Common adverse events in children include nausea, vomiting, headache, and skin reactions. [2][3]
- Renal function: No dose adjustment is required for children with normal renal function; specific dosing tables are provided for renal impairment in children who qualify for adult dosing (>40 kg). [2][3]